4//SEC Filing
Kendall Keith J 4
Accession 0001214659-22-003894
CIK 0001398733other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 11:24 AM ET
Size
5.4 KB
Accession
0001214659-22-003894
Insider Transaction Report
Form 4
Kendall Keith J
DirectorCEO and President
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-03-10+375,000→ 375,000 totalExercise: $2.55Exp: 2032-03-10→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001406834
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 11:24 AM ET
- Size
- 5.4 KB